A phase I/II dose escalation study to evaluate the pharmacokinetics, safety, and antiviral activity of beta-L-2'-Deoxycytidine-3'-monovaline ester (monoval-LdC) in adults with chronic hepatitis B

View Statistics Email Alert RSS Feed

Grant Data
Project Title
A phase I/II dose escalation study to evaluate the pharmacokinetics, safety, and antiviral activity of beta-L-2'-Deoxycytidine-3'-monovaline ester (monoval-LdC) in adults with chronic hepatitis B
Principal Investigator
Emeritus Professor Lai, Ching Lung   (Principal Investigator (PI))
Co-Investigator(s)
Professor Yuen Richard Man Fung   (Co-Investigator)
Duration
17
Start Date
2003-05-09
Amount
294276
Conference Title
A phase I/II dose escalation study to evaluate the pharmacokinetics, safety, and antiviral activity of beta-L-2'-Deoxycytidine-3'-monovaline ester (monoval-LdC) in adults with chronic hepatitis B
Presentation Title
Keywords
Chronic Hepatitis B
Discipline
Gastroenterology/Hepatobiliary
HKU Project Code
N/A
Grant Type
Idenix Pharmaceuticals, Inc - General Award
Funding Year
2002
Status
Completed